(Boursier.com) – The Air Force Department, in conjunction with the Department of Health and Human Services (HHS), has awarded a $ 30 million contract to Eurofins Genomics US for a new manufacturing base and expansion. Its capabilities for the production of furnaces used in COVID-19 diagnostic tests.
The new site will focus on the production of oligonucleotides (oligos) for molecular diagnostic testing. These are the most accurate method of identifying viruses and are used for a wide variety of applications. In fact, all PCR-based Govit-19 tests are based on molecular technology and are recognized as the most reliable type of Govit-19 test.
The new site will be located near the current Eurofins Genomics site in KY, Louisville, the logistics center for the Eurofins Group in the United States. The strategic location of the new site will allow rapid and reliable delivery of these key reactors across the country, which will mitigate supply chain problems and support national laboratory testing for COVID-19.
21 2021 Boursier.com
“Certified food fanatic. Extreme internet guru. Gamer. Evil beeraholic. Zombie ninja. Problem solver. Unapologetic alcohol lover.”
More Stories
US energy production hits new record
Rugby: Former Australia captain Michael Hooper has ended his career after his dream of competing in the Olympics evaporated.
Despite its lack of discipline, Australia prevailed against Georgia